<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336861">
  <stage>Registered</stage>
  <submitdate>27/04/2011</submitdate>
  <approvaldate>27/04/2011</approvaldate>
  <actrnumber>ACTRN12611000433909</actrnumber>
  <trial_identification>
    <studytitle>Effect of altering local anaesthetic concentration on nerve block duration for arthroscopic shoulder surgery</studytitle>
    <scientifictitle>Effect of altering ropivacaine concentration on interscalene block duration for arthroscopic shoulder surgery</scientifictitle>
    <utrn>U1111-1120-9031</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Shoulder arthroscopic surgery analgesia</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients undergoing elective arthroscopic shoulder surgery will receive an ultrasound guided interscalene nerve block with 20mls of a randomly allocated ropivacaine concentration.

Arm 1
0.1% ropivacaine

Arm 2
0.2% ropivacaine

Arm 3
0.375% ropivacaine

Arm 4
0.75% ropivacaine</interventions>
    <comparator>Active control - interscalene nerve block with 20mls of 0.75% ropivacaine</comparator>
    <control>Dose comparison</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Duration before analgesic effect of block wears off as reported by the patient</outcome>
      <timepoint>Checked at day 1 and day 2 post-operatively.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Opioid usage (converted to fentanyl equivalent)</outcome>
      <timepoint>Within first 24 hours following surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Shoulder pain as assessed using numeric verbal rating score at rest and on movement</outcome>
      <timepoint>15 minutes, 60 minutes, and 24 hours following surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Nausea, vomiting and antiemetic usage</outcome>
      <timepoint>Within first 24 hours of surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Motor block assessed by hand grip dynamometer</outcome>
      <timepoint>pre-op, in post anaesthetic care unit and the next day</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Respiratory function assessed by peak expiratory flow rate measured by a peak flow meter, and episodes of O2 saturation &lt; 93% measured by a pulse oximeter</outcome>
      <timepoint>pre-op, in post anaesthetic care unit and the next day</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Hoarse voice assessed clinically by anaesthetic nurse/doctor</outcome>
      <timepoint>pre-op, in post anaesthetic care unit and the next day</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Horners syndrome assessed clinically by anaesthetic nurse/doctor</outcome>
      <timepoint>pre-op, in post anaesthetic care unit and the next day</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Participant satisfaction with their analgesic care, scored with a verbal numeric scale 0-10.</outcome>
      <timepoint>before patient is discharged home</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Elective arthroscopic shoulder surgery
Age 18-80 years
ASA 1-3</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patient refusal

Previous involvement in this study

Contraindication to interscalene block (patient refusal, coagulopathy, sepsis, local infection, severe respiratory disease, allergy to ropivacaine)

Upper limb neurological disease or deficits 

Opioid tolerance (defined as use of &gt;30mg oral morphine/day or equivalent  fentanyl patch 12mcg/hr, buprenorphine 20mcg/hr, oxycodone &gt;20mg/day)

Contraindication to COX2 inhibitors/NSAIDs (renal impairment, NSAIDs/aspirin trigger asthma, active peptic ulcer disease, or allergy).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Numbered syringes that were prepared with the randomly allocated ropivacaine concentration</concealment>
    <sequence>Permuted block randomisation using online computer software</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/06/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>120</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>5041</postcode>
    <postcode>5042</postcode>
    <postcode>5168</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Jason Koerber</primarysponsorname>
    <primarysponsoraddress>Flinders Medical Centre
Flinders Drive
Bedford Park
South Australia
5042</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Southern Adelaide Health Service</fundingname>
      <fundingaddress>Flinders Medical Centre
Flinders Drive
Bedford Park
South Australia
5042</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Nathan Davis</sponsorname>
      <sponsoraddress>Flinders Medical Centre
Flinders Drive
Bedford Park
South Australia
5042</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Arthroscopic shoulder surgery may produce severe pain that is a challenge to control. Interscalene nerve blocks have been shown to be an excellent method of analgesia. It is not clear what concentration of local anaesthetic should be used for interscalene blocks to maximise pain relief and minimise side-effects. We aim to determine if lower compared to higher concentrations of ropivacaine (a local anaesthetic) can produce comparable pain relief duration with less side-effects.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>South Adelaide Health Service Research Ethics Committee</ethicname>
      <ethicaddress>Research Ethics Office
Flinders Medical Centre
Flinders Drive 
Bedford Park SA 5042</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>27/04/2011</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Jason Koerber</name>
      <address>Anaesthetic Department
Flinders Medical Centre
Flinders Drive
Bedford Park
South Australia
5042</address>
      <phone>+61 8 8204 5511</phone>
      <fax>+61 8 8204 5450</fax>
      <email>Jason.Koerber@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Jason Koerber</name>
      <address>Anaesthetic Department
Flinders Medical Centre
Flinders Drive
Bedford Park
South Australia
5042</address>
      <phone>+61 8 8204 5511</phone>
      <fax>+61 8 8204 5450</fax>
      <email>Jason.Koerber@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Jason Koerber</name>
      <address>Anaesthetic Department
Flinders Medical Centre
Flinders Drive
Bedford Park
South Australia
5042</address>
      <phone>+61 8 8204 5511</phone>
      <fax>+61 8 8204 5450</fax>
      <email>Jason.Koerber@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>